Lymphatic Interrupted: Do We Really Understand the Risks and Consequences?

por Mittendorf, Elizabeth A., Hunt, Kelly K.
Publicado 2009

Adoptive T-cell therapy for Leukemia

por Garber, Haven R, Mirza, Asma, Mittendorf, Elizabeth A, Alatrash, Gheath
Publicado 2014

Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer

por Kantor, Olga, Wong, Stephanie, Weiss, Anna, Metzger, Otto, Mittendorf, Elizabeth A., King, Tari A.
Publicado 2020

Association Between Time to Operation and Pathologic Stage in Ductal Carcinoma in Situ and Early-Stage Hormone Receptor-Positive Breast Cancer

por Minami, Christina A., Kantor, Olga, Weiss, Anna, Nakhlis, Faina, King, Tari A., Mittendorf, Elizabeth A.
Publicado 2020

Survival Advantage in Patients with Metastatic Breast Cancer Receiving Endocrine Therapy plus Sialyl Tn-KLH Vaccine: Post Hoc Analysis of a Large Randomized Trial

por Ibrahim, Nuhad K., Murray, James L., Zhou, Dapeng, Mittendorf, Elizabeth A., Sample, Dory, Tautchin, Michael, Miles, David
Publicado 2013

Outcomes of Sentinel Lymph Node Dissection Alone vs. Axillary Lymph Node Dissection in Early Stage Invasive Lobular Carcinoma: A Retrospective Study of the Surveillance, Epidemiolo...

por Wang, Jun, Mittendorf, Elizabeth A., Sahin, Aysegul A., Yi, Min, Caudle, Abigail, Hunt, Kelly K., Wu, Yun
Publicado 2014

Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer

por Hartl, Christina A., Bertschi, Adrian, Puerto, Regina Bou, Andresen, Carolin, Cheney, Emily M., Mittendorf, Elizabeth A., Guerriero, Jennifer L., Goldberg, Michael S.
Publicado 2019

Assessment of Oncologists’ Perspectives on Omission of Sentinel Lymph Node Biopsy in Women 70 Years and Older With Early-Stage Hormone Receptor–Positive Breast Cancer

por Minami, Christina A., Bryan, Ava F., Freedman, Rachel A., Revette, Anna C., Schonberg, Mara A., King, Tari A., Mittendorf, Elizabeth A.
Publicado 2022

Metabolic abnormalities and survival among patients with non-metastatic breast cancer

por Zimbalist, Alexa S., Caan, Bette J., Chen, Wendy Y., Mittendorf, Elizabeth A., Dillon, Deborah A. R., Quesenberry, Charles, Cespedes Feliciano, Elizabeth M.
Publicado 2022

Immunotherapy for early triple negative breast cancer: research agenda for the next decade

por Tarantino, Paolo, Corti, Chiara, Schmid, Peter, Cortes, Javier, Mittendorf, Elizabeth A., Rugo, Hope, Tolaney, Sara M., Bianchini, Giampaolo, Andrè, Fabrice, Curigliano, Giuseppe
Publicado 2022

Crossover Effects of Estrogen Receptor Status on Breast Cancer-Specific Hazard Rates by Age and Race

por Ren, Yu, Black, Dalliah M., Mittendorf, Elizabeth A., Liu, Peijun, Li, Xu, Du, Xianglin L., He, Jianjun, Yang, Jin, Hunt, Kelly K., Yi, Min
Publicado 2014

Neoadjuvant immunotherapy across cancers: meeting report from the Immunotherapy Bridge—December 1st–2nd, 2021

por Burton, Elizabeth M., Amaria, Rodabe N., Cascone, Tina, Chalabi, Myriam, Gross, Neil D., Mittendorf, Elizabeth A., Scolyer, Richard A., Sharma, Padmanee, Ascierto, Paolo A.
Publicado 2022

Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer

por Lal, Jessica Castrillon, Townsend, Madeline G., Mehta, Anita K., Oliwa, Madisson, Miller, Eric, Sotayo, Alaba, Cheney, Emily, Mittendorf, Elizabeth A., Letai, Anthony, Guerriero, Jennifer L.
Publicado 2021

A Novel Interaction Between HER2/neu and Cyclin E in Breast Cancer

por Mittendorf, Elizabeth A., Liu, Yanna, Tucker, Susan L., McKenzie, Tamra, Qiao, Na, Akli, Said, Biernacka, Anna, Liu, Yan, Meijer, Laurent, Keyomarsi, Khandan, Hunt, Kelly K.
Publicado 2010

Fucosylation enhances activity of cytotoxic T lymphocytes against breast cancer

por Qiao, Na, Mittendorf, Elizabeth A, Zhang, Mao, Sukhumalchandra, Pariya, Polan, Jodie L, Neal, Samantha, Rauf, Mikael, Gall, Victor, Philips, Anne V, Shpall, Elizabeth J, Alatrash, Gheath
Publicado 2015

Pro-inflammatory megakaryocyte gene expression in murine models of breast cancer

por Roweth, Harvey G., Malloy, Michael W., Goreczny, Gregory J., Becker, Isabelle C., Guo, Qiuchen, Mittendorf, Elizabeth A., Italiano, Joseph E., McAllister, Sandra S., Battinelli, Elisabeth M.
Publicado 2022

Preliminary results for the phase 1 trial of a folate receptor alpha adjuvant cancer vaccine in ovarian and endometrial cancer patients

por Berry, John S, Schneble, Erika J, Trappey, Alfred F, Vreeland, Timothy J, Clifton, Guy T, Hale, Diane F, Sears, Alan K, Ponniah, Sathibalan, Mittendorf, Elizabeth A, Peoples, George E
Publicado 2013

Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine

por Jackson, Doreen, Qiao, Na, Greene, Julia M, Hale, Diane, Berry, John, Trappey, Alfred, Vreeland, Timothy, Clifton, Guy, Ibrahim, Nuhad, Toms, Annie, Peoples, George E, Mittendorf, Elizabeth A
Publicado 2015

Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy

por Dominici, Laura S, Mittendorf, Elizabeth A, Wang, Xumei, Liu, Jun, Kuerer, Henry M, Hunt, Kelly K, Brewster, Abenaa, Babiera, Gildy V, Buchholz, Thomas A, Meric-Bernstam, Funda, Bedrosian, Isabelle
Publicado 2012

DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine

por Anastasopoulou, Eleftheria A, Tzonis, Panagiotis, Fortis, Sotirios P, Mahaira, Louisa, Vaxevanis, Christoforos, Ardavanis, Alexandros, Mittendorf, Elizabeth A, Peoples, George E, Baxevanis, Constantin N, Papamichail, Michael, Perez, Sonia A
Publicado 2015